Non‐Hodgkin lymphoma after treatment for classical Hodgkin lymphoma: a report from the German Hodgkin Study Group

Summary Data on non‐Hodgkin lymphoma (NHL) after classical Hodgkin lymphoma (cHL) are scarce. We therefore performed a retrospective analysis comprising 11·841 cHL patients who had first‐line treatment within the randomized German Hodgkin Study Group (GHSG) HD7–HD15 studies. After a median follow‐up...

Full description

Saved in:
Bibliographic Details
Published in:British journal of haematology 2021-05, Vol.193 (3), p.515-519
Main Authors: Eichenauer, Dennis A., Müller, Horst, Elger, Leonard, Goergen, Helen, Fuchs, Michael, Kreissl, Stefanie, Böll, Boris, Diehl, Volker, Tresckow, Bastian, Borchmann, Peter, Engert, Andreas
Format: Article
Language:English
Subjects:
Classical Hodgkin lymphoma
Diagnosis
Hematology
incidence
Lymphoma
Non-Hodgkin's lymphoma
non‐Hodgkin lymphoma
prognosis
Survival
treatment
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Data on non‐Hodgkin lymphoma (NHL) after classical Hodgkin lymphoma (cHL) are scarce. We therefore performed a retrospective analysis comprising 11·841 cHL patients who had first‐line treatment within the randomized German Hodgkin Study Group (GHSG) HD7–HD15 studies. After a median follow‐up of 106 months, 175 patients (1·5%) had developed NHL. The median time to NHL was 44 months, the median age at NHL diagnosis was 54 years. The five‐year event‐free survival and overall survival estimates from the diagnosis of NHL were 36·9% and 44·2%, respectively. Thus, NHL after cHL is a rare event primarily affecting older individuals and often resulting in the patient´s death.
ISSN:0007-1048
1365-2141
DOI:10.1111/bjh.17327